Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research. Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
